China SXT Pharmaceuticals, Inc. (SXTC): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$2.35M
Year ended 2025-03-31
$1.48M2017-03-31: $113.9K2018-03-31: $1.48M2019-03-31: -$296.6K2020-03-31: $803.4K2024-03-31: -$1.94M2025-03-31: -$2.35M-$2.35M
2017-03-31 Free Cash Flow (USD) 2025-03-31
Period endedFree Cash FlowChange YoYSource filing
2025-03-31-$2.35Mn/m2026-07-01, From 2024-04-01
2024-03-31-$1.94Mn/a2026-07-01, From 2023-04-01
No annual figure between 2020-03-31 and 2024-03-31.
2020-03-31$803.4Kn/m2023-05-19, From 2019-04-01
2019-03-31-$296.6Kn/m2021-08-13, From 2018-04-01
2018-03-31$1.48Mn/m2020-07-31, From 2017-04-01
2017-03-31$113.9Kn/a2019-08-15, From 2016-04-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
China SXT Pharmaceuticals, Inc. (SXTC)2025-03-31-$2.35Mn/m
Bespoke Extracts, Inc. (BSPK)2024-12-31-$889.8Kn/a
Longeveron Inc. (LGVN)2025-12-31-$18.89Mn/m
Dare Bioscience, Inc. (DARE)2025-12-31-$10.29Mn/m
Vistagen Therapeutics, Inc. (VTGN)2024-03-31-$25.81Mn/m
IGC Pharma, Inc. (IGC)2025-03-31-$4.91Mn/m
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31-$6.99Mn/m
Shattuck Labs, Inc. (STTK)2025-12-31-$39.95Mn/m
Cannapharmarx, Inc. (CPMD)2025-12-31-$794.6Kn/m

Compare SXTC, BSPK, LGVN, DARE side by side · Screen every company in Pharmaceutical Preparations ↗